Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Stock Holdings Reduced by Thompson Siegel & Walmsley LLC

Thompson Siegel & Walmsley LLC lowered its position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 4.6% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 6,633,146 shares of the pharmacy operator’s stock after selling 322,734 shares during the quarter. Thompson Siegel & Walmsley LLC owned approximately 0.77% of Walgreens Boots Alliance worth $61,887,000 at the end of the most recent quarter.

Several other large investors also recently made changes to their positions in the stock. Brooklyn Investment Group boosted its stake in shares of Walgreens Boots Alliance by 21.1% during the 4th quarter. Brooklyn Investment Group now owns 4,757 shares of the pharmacy operator’s stock worth $44,000 after acquiring an additional 830 shares in the last quarter. First Financial Corp IN boosted its stake in shares of Walgreens Boots Alliance by 49.2% during the 4th quarter. First Financial Corp IN now owns 2,685 shares of the pharmacy operator’s stock worth $25,000 after acquiring an additional 885 shares in the last quarter. CWA Asset Management Group LLC boosted its stake in shares of Walgreens Boots Alliance by 9.2% during the 4th quarter. CWA Asset Management Group LLC now owns 12,893 shares of the pharmacy operator’s stock worth $120,000 after acquiring an additional 1,084 shares in the last quarter. Metis Global Partners LLC boosted its stake in shares of Walgreens Boots Alliance by 4.9% during the 4th quarter. Metis Global Partners LLC now owns 23,815 shares of the pharmacy operator’s stock worth $222,000 after acquiring an additional 1,118 shares in the last quarter. Finally, OLD Second National Bank of Aurora lifted its position in shares of Walgreens Boots Alliance by 35.1% during the 3rd quarter. OLD Second National Bank of Aurora now owns 4,562 shares of the pharmacy operator’s stock worth $41,000 after purchasing an additional 1,185 shares during the last quarter. Institutional investors own 58.59% of the company’s stock.

Walgreens Boots Alliance Price Performance

Shares of WBA stock opened at $11.20 on Thursday. The stock has a 50 day moving average of $10.75 and a two-hundred day moving average of $9.74. The company has a current ratio of 0.64, a quick ratio of 0.30 and a debt-to-equity ratio of 0.68. Walgreens Boots Alliance, Inc. has a 12 month low of $8.08 and a 12 month high of $22.05. The company has a market capitalization of $9.68 billion, a P/E ratio of -1.09, a P/E/G ratio of 1.31 and a beta of 0.62.

Walgreens Boots Alliance (NASDAQ:WBA) last posted its earnings results on Friday, January 10th. The pharmacy operator reported $0.51 EPS for the quarter, topping the consensus estimate of $0.38 by $0.13. The business had revenue of $39.50 billion during the quarter, compared to the consensus estimate of $37.40 billion. Walgreens Boots Alliance had a positive return on equity of 17.61% and a negative net margin of 5.87%. Walgreens Boots Alliance’s revenue was up 7.6% on a year-over-year basis. During the same quarter last year, the company earned $0.66 EPS. As a group, equities analysts expect that Walgreens Boots Alliance, Inc. will post 1.6 EPS for the current year.

Analysts Set New Price Targets

WBA has been the subject of several research analyst reports. Evercore ISI boosted their price objective on Walgreens Boots Alliance from $9.00 to $12.00 and gave the stock an “in-line” rating in a research report on Monday, January 13th. Royal Bank of Canada boosted their price objective on Walgreens Boots Alliance from $9.00 to $12.00 and gave the stock a “sector perform” rating in a research report on Wednesday, January 15th. Truist Financial cut their price objective on Walgreens Boots Alliance from $13.00 to $12.00 and set a “hold” rating for the company in a research report on Friday, January 31st. Bank of America boosted their price objective on Walgreens Boots Alliance from $7.50 to $8.50 and gave the stock an “underperform” rating in a research report on Monday, January 13th. Finally, Wolfe Research raised Walgreens Boots Alliance to a “hold” rating in a research report on Monday, February 24th. Four investment analysts have rated the stock with a sell rating, eight have issued a hold rating and two have given a buy rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus price target of $11.54.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.